Effect of Nonviral Factors on Hepatitis C Recurrence After Liver Transplantation

Objective:Hepatitis C (HCV) is now the most common indication for orthotopic liver transplantation (OLT). While graft reinfection remains universal, progression to graft cirrhosis is highly variable. This study examined donor, recipient, and operative variables to identify factors that affect recurrence of HCV post-OLT to facilitate graft-recipient matching. Methods:Retrospective review of 307 patients who underwent OLT for HCV over a 10-year period at our center. Recurrence of HCV was identified by the presence of biochemical graft dysfunction and concurrent liver biopsy showing diagnostic pathologic features. Time to recurrence was the endpoint for statistical analysis. Five donor, 6 recipient, and 2 operative variables that may affect recurrence were analyzed by univariate comparison and Cox proportional hazard regression models. Results:Recurrence-free survival in the 307 study patients was 69% and 34% at 1 and 5 years, respectively. Four predictive variables related to either donor or recipient characteristics were identified. Advanced donor age, prolonged donor hospitalization, increasing recipient age, and elevated recipient MELD scores were found to increase the relative risk of HCV recurrence. Examination of HLA disparity between donors and recipients demonstrated no correlation between class I or class II mismatches and recurrence-free survival. Conclusions:We have identified donor and recipient characteristics that significantly predict hepatitis C recurrence following liver transplantation. These factors are identifiable before transplant and, if considered when matching donors to HCV recipients, may decrease the incidence of HCV recurrence after OLT. A change in the current national liver allocation system would be needed to realize the full value of this benefit.

[1]  V. Caron,et al.  United states. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  E. Lyden,et al.  Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  S. Hossain,et al.  Recurrent hepatitis C after retransplantation: Factors affecting graft and patient outcome , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  T. Starzl,et al.  Immunosuppression for liver transplantation in HCV‐infected patients: Mechanism‐based principles , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  G. Everson,et al.  Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy , 2005, Hepatology.

[6]  J. Hiatt,et al.  Analysis of Long-term Outcomes of 3200 Liver Transplantations Over Two Decades: A Single-Center Experience , 2005, Annals of surgery.

[7]  J. Hiatt,et al.  Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  D. Theriaque,et al.  One‐year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  R. Fisher,et al.  Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  J. Llovet,et al.  Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation , 2004, Hepatology.

[11]  J. Galanko,et al.  Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  A. Zekry,et al.  Mechanisms of HCV reinfection and allograft damage after liver transplantation. , 2004, Journal of hepatology.

[13]  K. Reddy,et al.  Factors that influence the severity of recurrent hepatitis C virus following liver transplantation. , 2003, Clinics in liver disease.

[14]  R. Gish,et al.  A model to predict severe HCV‐related disease following liver transplantation , 2003, Hepatology.

[15]  Mark J. Thomas,et al.  Pretransplant MELD Score As a Predictor of Outcome After Liver Transplantation for Chronic Hepatitis C , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  G. Davis,et al.  Projecting future complications of chronic hepatitis C in the United States , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  J. Albrecht,et al.  Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. , 2003, Gastroenterology.

[18]  J. Mir,et al.  Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosis , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  H. El‐Serag.  Hepatocellular carcinoma and hepatitis C in the United States , 2002, Hepatology.

[20]  P. Gow,et al.  Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C , 2002, Gut.

[21]  R. Wiesner,et al.  Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  X. Forns,et al.  Hepatitis C virus kinetics during and immediately after liver transplantation , 2002, Hepatology.

[23]  O. Weiland,et al.  Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. , 2002, Journal of hepatology.

[24]  E. Collisson,et al.  A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients , 2001, Annals of surgery.

[25]  Z. Goodman,et al.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.

[26]  A. Airoldi,et al.  Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial. , 2001, Transplantation proceedings.

[27]  V. Mazzaferro,et al.  Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. , 2001, Transplantation proceedings.

[28]  G. Klintmalm,et al.  Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  L. Ferrell,et al.  HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.

[30]  N. Bourgeois.  Hepatitis C recurrence after liver transplantation. , 1999, Acta gastro-enterologica Belgica.

[31]  E. Fagan.  Intrahepatic cholestasis of pregnancy. , 1999, Clinics in liver disease.

[32]  M. Bronner,et al.  Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. , 1998, Tissue antigens.

[33]  Charles M. Miller,et al.  The efficacy of prophylactic interferon alfa‐2b in preventing recurrent hepatitis C after liver transplantation , 1998, Hepatology.

[34]  R. Wiesner,et al.  Predictors of patient and graft survival following liver transplantation for hepatitis C , 1998, Hepatology.

[35]  M. Houghton,et al.  Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. , 1998, Gastroenterology.

[36]  G. Klintmalm,et al.  Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. , 1998, Transplantation.

[37]  Nina Singh,et al.  Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant recipients : A prospective, randomized, controlled trial , 1998 .

[38]  R. Sorelle.  United Network for Organ Sharing. , 1997, Circulation.

[39]  M. Picot,et al.  Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  J. Crespo,et al.  Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia. , 1997, The American journal of gastroenterology.

[41]  S. Thung,et al.  Retransplantation for recurrent hepatitis C. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[42]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[43]  Randall G. Lee,et al.  Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. , 1997, The Journal of infectious diseases.

[44]  R. Busuttil,et al.  Graft loss following liver transplantation in patients with chronic hepatitis C. , 1996, Transplantation.

[45]  B. Portmann,et al.  Long-term outcome of hepatitis C infection after liver transplantation. , 1996, The New England journal of medicine.

[46]  T. Starzl,et al.  The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. , 1995, Transplantation.

[47]  I. Marino,et al.  Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. , 1998, Transplantation.

[48]  Nina Singh,et al.  INTERFERON-a FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS , 1998 .